RAPT Therapeutics to Present at Upcoming Investor Conferences
September 03 2021 - 8:00AM
RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage,
immunology-based biopharmaceutical company focused on
discovering, developing and commercializing oral small molecule
therapies for patients with significant unmet needs in oncology and
inflammatory diseases, today announced that Brian Wong, M.D.,
Ph.D., President and CEO, will present at the following investor
conferences in the first half of September:
- Wells Fargo 2021 Virtual Healthcare
Conference Thursday, September 9, 2021 at 8:00 a.m. EST
- H.C. Wainwright 23rd Annual Global
Investment Conference presentation available on-demand Monday,
September 13, 2021 at 7:00 a.m. EST
To access the live webcasts or subsequent archived recordings of
the company presentations, please visit the RAPT Therapeutics
website at https://investors.rapt.com/events-and-presentations.
About RAPT Therapeutics, Inc.RAPT
Therapeutics is a clinical stage immunology-based biopharmaceutical
company focused on discovering, developing and commercializing oral
small molecule therapies for patients with significant unmet needs
in oncology and inflammatory diseases. Utilizing its proprietary
discovery and development engine, the Company is developing highly
selective small molecules designed to modulate the critical immune
drivers underlying these diseases. RAPT has discovered and advanced
two unique drug candidates, FLX475 and RPT193, each targeting C-C
motif chemokine receptor 4 (CCR4), for the treatment of cancer and
inflammation, respectively. The Company is also pursuing a range of
targets that are in the discovery stage of development.
RAPT Media Contact:Aljanae
Reynoldsareynolds@wheelhouselsa.com
RAPT Investor Contact:Sylvia
Wheelerswheeler@wheelhouselsa.com
RAPT Therapeutics (NASDAQ:RAPT)
Historical Stock Chart
From Aug 2024 to Sep 2024
RAPT Therapeutics (NASDAQ:RAPT)
Historical Stock Chart
From Sep 2023 to Sep 2024